KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationInvestment in Debt & EquityLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Issuances (2019 - 2020)

Inovio Pharmaceuticals' Long-Term Debt Issuances history spans 2 years, with the latest figure at $171620.0 for Q2 2020.

  • For Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to $171620.0; the TTM value through Sep 2021 reached $171620.0, up 100.18%, while the annual FY2020 figure was $171620.0, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q2 2020 was $171620.0 at Inovio Pharmaceuticals, up from -$93.4 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $75.7 million in Q1 2019 and bottomed at -$93.4 million in Q4 2019.